According to the Complaint, Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. Cronos seeks to invest in companies either licensed, or actively seeking a license, to producemedical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations (MMPR). The Company typically invests in companies based in Canada.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.